Hetero, Cipla's Remdesivirs Hit India Market, 'Surplus' Envisaged By August

Prices Well Below $100/vial

Coins, money and COVID-19 on scale. Concepts of economics against coronavirus. Balancing and managing losses. 3D render
Hetero, Cipla Hit Market With Generic Remdesivir • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from India

More from Focus On Asia